Teva Pharmaceutical Industries Ltd. — CAC CAC-UDRP-101431

CAC CAC-UDRP-101431 (Apr. 2017)

Case

CAC CAC-UDRP-101431 (Apr. 2017)

Decision date

2017-04-11

Outcome

5 transferred

Policy

UDRP

Scope

Common control

Public attribution

Firm named; individual not named

Evidence summary

Initially common WHOIS holder; changed identities after service; related registrar and parking patterns.

Panel finding

Panel treated the identity changes as cyberflight and allowed consolidation.

Qualification

RiskIQ only; five domains. Individual not expressly named.

Domains adjudicated

5 domains adjudicated: ajovy.com, cenmira.com, copaxoneclick.com, pernuvi.com, remfaso.com

Source and provenance

This page is a Matkowsky.com case record derived from the verified published decision and controlled corpus metadata. The official provider decision remains the authoritative source and is retained as provenance; this site does not send visitors to the provider decision unless a visitor specifically asks for that official link.